HIGHLIGHTS
- who: Roxane Mari from the The University of Queensland, Australia have published the paper: Durable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report, in the Journal: (JOURNAL)
- what: The authors report the case of a refractory bullous pemphigoid (BP) following nivolumab discontinuation in metastatic ccRCC with durable response.
SUMMARY
(International Metastatic RCC Database Consortium). It has been suggested that BP180 may be a common antigen, found both in the dermo-epidermal junction and on the surface of malignant melanocytic tumor . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.